BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25450691)

  • 1. TRPM7 is required for ovarian cancer cell growth, migration and invasion.
    Wang J; Liao QJ; Zhang Y; Zhou H; Luo CH; Tang J; Wang Y; Tang Y; Zhao M; Zhao XH; Zhang QY; Xiao L
    Biochem Biophys Res Commun; 2014 Nov; 454(4):547-53. PubMed ID: 25450691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
    Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
    J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing TRPM7 in mouse cortical astrocytes impairs cell proliferation and migration via ERK and JNK signaling pathways.
    Zeng Z; Leng T; Feng X; Sun H; Inoue K; Zhu L; Xiong ZG
    PLoS One; 2015; 10(3):e0119912. PubMed ID: 25799367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
    Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
    Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of transient receptor potential melastatin member 7 prevents migration and invasion of renal cell carcinoma cells via inactivation of the Src and Akt pathway.
    Ha YS; Kim YY; Yu NH; Chun SY; Choi SH; Lee JN; Kim BS; Yoo ES; Kwon TG
    Investig Clin Urol; 2018 Jul; 59(4):263-274. PubMed ID: 29984342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion.
    Song C; Bae Y; Jun J; Lee H; Kim ND; Lee KB; Hur W; Park JY; Sim T
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):947-957. PubMed ID: 28161478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-543 inhibites cervical cancer growth and metastasis by targeting TRPM7.
    Liu X; Gan L; Zhang J
    Chem Biol Interact; 2019 Apr; 302():83-92. PubMed ID: 30710498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin-induced vascular endothelial cell migration is dependent on TLR4/NF-κB pathway, NAD(P)H oxidase activation, and transient receptor potential melastatin 7 calcium channel activity.
    Sarmiento D; Montorfano I; Cáceres M; Echeverría C; Fernández R; Cabello-Verrugio C; Cerda O; Tapia P; Simon F
    Int J Biochem Cell Biol; 2014 Oct; 55():11-23. PubMed ID: 25130439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.
    Su F; Wang BF; Zhang T; Hou XM; Feng MH
    Cancer Biomark; 2019; 26(4):451-460. PubMed ID: 31640089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Oncogenic Roles of the TRPM7 Chanzyme.
    Gautier M; Perrière M; Monet M; Vanlaeys A; Korichneva I; Dhennin-Duthille I; Ouadid-Ahidouch H
    Curr Med Chem; 2016; 23(36):4092-4107. PubMed ID: 27604090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.
    Leng TD; Li MH; Shen JF; Liu ML; Li XB; Sun HW; Branigan D; Zeng Z; Si HF; Li J; Chen J; Xiong ZG
    CNS Neurosci Ther; 2015 Mar; 21(3):252-61. PubMed ID: 25438992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer.
    Lee EH; Chun SY; Kim B; Yoon BH; Lee JN; Kim BS; Yoo ES; Lee S; Song PH; Kwon TG; Ha YS
    BMC Urol; 2020 Sep; 20(1):145. PubMed ID: 32907556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of TRPM7 in ovarian cancer.
    Wang ZB; Zhang X; Xiao F; Liu ZQ; Liao QJ; Wu N; Wang J
    Biochem Pharmacol; 2023 Nov; 217():115857. PubMed ID: 37839677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor signaling through transient receptor potential melastatin 7 cation channel regulates vascular smooth muscle cell function.
    Zou ZG; Rios FJ; Neves KB; Alves-Lopes R; Ling J; Baillie GS; Gao X; Fuller W; Camargo LL; Gudermann T; Chubanov V; Montezano AC; Touyz RM
    Clin Sci (Lond); 2020 Aug; 134(15):2019-2035. PubMed ID: 32706027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2.
    Chen Y; Yu Y; Sun S; Wang Z; Liu P; Liu S; Jiang J
    Exp Cell Res; 2016 Nov; 349(1):68-76. PubMed ID: 27693494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPM7 regulates vascular endothelial cell adhesion and tube formation.
    Zeng Z; Inoue K; Sun H; Leng T; Feng X; Zhu L; Xiong ZG
    Am J Physiol Cell Physiol; 2015 Feb; 308(4):C308-18. PubMed ID: 25472964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 increases migration and proliferation of human glioblastoma cells by activating transient receptor potential melastatin 7 channels.
    Tian Y; Yang T; Yu S; Liu C; He M; Hu C
    J Cell Mol Med; 2018 Dec; 22(12):6327-6337. PubMed ID: 30338939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.
    Gao SL; Kong CZ; Zhang Z; Li ZL; Bi JB; Liu XK
    Oncol Rep; 2017 Oct; 38(4):1967-1976. PubMed ID: 28791418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of TRPM7 is associated with poor prognosis in human ovarian carcinoma.
    Wang J; Xiao L; Luo CH; Zhou H; Hu J; Tang YX; Fang KN; Zhang Y
    Asian Pac J Cancer Prev; 2014; 15(9):3955-8. PubMed ID: 24935580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration.
    Rybarczyk P; Gautier M; Hague F; Dhennin-Duthille I; Chatelain D; Kerr-Conte J; Pattou F; Regimbeau JM; Sevestre H; Ouadid-Ahidouch H
    Int J Cancer; 2012 Sep; 131(6):E851-61. PubMed ID: 22323115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.